Fenretinide regulates macrophage polarization to protect against experimental colitis induced by dextran sulfate sodium

References

• Baumgart DC, Carding SR. Inflammatory bowel disease: cause and immunobiology. Lancet. 2007;369:1627–1640.
   PubMed Web of Science ®Google Scholar
• Quezada SM, McLean LP, Cross RK. Adverse events in IBD therapy: the 2018 update. Expert Rev Gastroenterol Hepatol. 2018;12:1183–1191.
   PubMed Web of Science ®Google Scholar
• Wang Y, Parker CE, Bhanji T, et al. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis. Cochrane Database Syst Rev. 2016;4:Cd000543.
   PubMed Web of Science ®Google Scholar
• Gallo G, Kotze PG, Spinelli A. Surgery in ulcerative colitis: When? How? Best Pract Res Clin Gastroenterol. 2018;32-33:71–78.
   PubMed Web of Science ®Google Scholar
• Pereira R, Lago P, Faria R, et al. Safety of anti-TNF therapies in immune-mediated inflammatory diseases: focus on infections and malignancy. Drug Dev Res. 2015;76:419–427.
   PubMed Web of Science ®Google Scholar
• Danese S, Siegel CA, Peyrin-Biroulet L. Review article: integrating budesonide-MMX into treatment algorithms for mild-to-moderate ulcerative colitis. Aliment Pharmacol Ther. 2014;39:1095–1103.
   PubMed Web of Science ®Google Scholar
• Gren ST, Grip O. Role of monocytes and intestinal macrophages in Crohn’s disease and ulcerative colitis. Inflamm Bowel Dis. 2016;22:1992–1998.
   PubMed Web of Science ®Google Scholar
• Nolte A, Junginger J, Baum B, et al. Heterogeneity of macrophages in canine histiocytic ulcerative colitis. Innate Immun. 2017;23:228–239.
   PubMed Web of Science ®Google Scholar
• Zhang X, Xu F, Liu L, et al. (+)-Borneol improves the efficacy of edaravone against DSS-induced colitis by promoting M2 macrophages polarization via JAK2-STAT3 signaling pathway. Int Immunopharmacol. 2017;53:1–10.
   PubMed Web of Science ®Google Scholar
• Song S, An J, Li Y, et al. Electroacupuncture at ST-36 ameliorates DSS-induced acute colitis via regulating macrophage polarization induced by suppressing NLRP3/IL-1β and promoting Nrf2/HO-1. Mol Immunol. 2019;106:143–152.
   PubMed Web of Science ®Google Scholar
• Cooper JP, Reynolds CP, Cho H, et al. Clinical development of fenretinide as an antineoplastic drug: pharmacology perspectives. Exp Biol Med. 2017;242:1178–1184.
   Web of Science ®Google Scholar
• Kanagaratham C, Kalivodová A, Najdekr L, et al. Fenretinide prevents inflammation and airway hyperresponsiveness in a mouse model of allergic asthma. Am J Respir Cell Mol Biol. 2014;51:783–792.
   PubMed Web of Science ®Google Scholar
• Lin CH, Lee SY, Zhang CC, et al. Fenretinide inhibits macrophage inflammatory mediators and controls hypertension in spontaneously hypertensive rats via the peroxisome proliferator-activated receptor gamma pathway. Drug Des Devel Ther. 2016;10:3591–3597.
   PubMed Web of Science ®Google Scholar
• Dong R, Gong Y, Meng W, et al. The involvement of M2 macrophage polarization inhibition in fenretinide-mediated chemopreventive effects on colon cancer. Cancer Lett. 2017;388:43–53.
   PubMed Web of Science ®Google Scholar
• Wang K, Li YF, Lv Q, et al. Bergenin, acting as an agonist of PPARγ, ameliorates experimental colitis in mice through improving expression of SIRT1, and therefore inhibiting NF-κB-mediated macrophage activation. Front Pharmacol. 2017;8:981.
   PubMed Web of Science ®Google Scholar
• Naskar D, Teng F, Felix KM, et al. Synthetic retinoid AM80 ameliorates lung and arthritic autoimmune responses by inhibiting T follicular helper and Th17 cell responses. J Immunol (Baltimore, Md). 1950;2017(198):1855–1864.
   Google Scholar
• Orfanos CE, Bauer R. Evidence for anti-inflammatory activities of oral synthetic retinoids: experimental findings and clinical experience. Br J Dermatol. 1983;109(Suppl 25):55–60.
   PubMedGoogle Scholar
• Ordás I, Eckmann L, Talamini M, et al. Ulcerative colitis. Lancet. 2012;380:1606–1619.
   PubMed Web of Science ®Google Scholar
• Dharmani P, Chadee K. Biologic therapies against inflammatory bowel disease: a dysregulated immune system and the cross talk with gastrointestinal mucosa hold the key. Curr Mol Pharmacol. 2008;1:195–212.
   PubMedGoogle Scholar
• Friedrich M, Pohin M, Powrie F. Cytokine networks in the pathophysiology of inflammatory bowel disease. Immunity. 2019;50:992–1006.
   PubMed Web of Science ®Google Scholar
• Yu H, Valerio M, Bielawski J. Fenretinide inhibited de novo ceramide synthesis and proinflammatory cytokines induced by Aggregatibacter actinomycetemcomitans. J Lipid Res. 2013;54:189–201.
   PubMed Web of Science ®Google Scholar
• Lee SM, Cheung CY, Nicholls JM, et al. Hyperinduction of cyclooxygenase-2-mediated proinflammatory cascade: a mechanism for the pathogenesis of avian influenza H5N1 infection. J Infect Dis. 2008;198:525–535.
   PubMed Web of Science ®Google Scholar
• Porcheray F, Viaud S, Rimaniol, AC, et al. Macrophage activation switching: an asset for the resolution of inflammation. Clin Exp Immunol. 2005;142:481–489.
   PubMed Web of Science ®Google Scholar
• Gordon S. Alternative activation of macrophages. Nat Rev Immunol. 2003;3:23–35.
   PubMed Web of Science ®Google Scholar
• Murray PJ, Wynn TA. Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol. 2011;11:723–737.
   PubMed Web of Science ®Google Scholar
• Cao H, Liu J, Shen P, et al. Protective effect of naringin on DSS-induced ulcerative colitis in mice. J Agric Food Chem. 2018;66:13133–13140.
   Google Scholar
• Tian X, Peng Z, Luo S, et al. Aesculin protects against DSS-Induced colitis though activating PPARγ and inhibiting NF-кB pathway. Eur J Pharmacol. 2019;857:172453.
   PubMed Web of Science ®Google Scholar
• Shah YM, Morimura K, Gonzalez FJ. Expression of peroxisome proliferator-activated receptor-gamma in macrophage suppresses experimentally induced colitis. Am J Physiol Gastrointest Liver Physiol. 2007;292:G657–66.
   PubMed Web of Science ®Google Scholar
• Bouhlel MA, Derudas B, Rigamonti E, et al. PPARgamma activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties. Cell Metab. 2007;6:137–143.
   PubMed Web of Science ®Google Scholar
• Li T, Zheng LN, Han XH. Fenretinide attenuates lipopolysaccharide (LPS)-induced blood-brain barrier (BBB) and depressive-like behavior in mice by targeting Nrf-2 signaling. Biomed Pharmacothe. 2020;125:109680.
   PubMed Web of Science ®Google Scholar
• Saber S, Basuony M, Eldin AS. Telmisartan ameliorates dextran sodium sulfate-induced colitis in rats by modulating NF-κB signalling in the context of PPARγ agonistic activity. Arch Biochem Biophys. 2019;671:185–195.
   PubMed Web of Science ®Google Scholar